NDAC
This article was originally published in The Tan Sheet
Executive Summary
Last scheduled 1999 meeting, Dec. 2-3, has been canceled due to lack of agenda items. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7-8. NDAC last met on July 20 with the Arthritis Advisory Committee to consider the Rx-to-OTC switch of Merck's Flexeril 5 mg (1"The Tan Sheet" July 26, pp. 3-9)
You may also be interested in...
NDAC
Committee charter renewed for two years, expiring Aug. 27, 2001. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7 and 9. The FDA committee's last scheduled 1999 meeting, Dec. 2-3, was canceled for lack of agenda items (1"The Tan Sheet" Oct. 25, In Brief)
NDAC
Committee charter renewed for two years, expiring Aug. 27, 2001. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7 and 9. The FDA committee's last scheduled 1999 meeting, Dec. 2-3, was canceled for lack of agenda items (1"The Tan Sheet" Oct. 25, In Brief)
NDAC
Committee charter renewed for two years, expiring Aug. 27, 2001. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7 and 9. The FDA committee's last scheduled 1999 meeting, Dec. 2-3, was canceled for lack of agenda items (1"The Tan Sheet" Oct. 25, In Brief)